Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Neuron ; 107(5): 836-853.e11, 2020 09 09.
Article in English | MEDLINE | ID: mdl-32574559

ABSTRACT

The resolution and dimensionality with which biologists can characterize cell types have expanded dramatically in recent years, and intersectional consideration of such features (e.g., multiple gene expression and anatomical parameters) is increasingly understood to be essential. At the same time, genetically targeted technology for writing in and reading out activity patterns for cells in living organisms has enabled causal investigation in physiology and behavior; however, cell-type-specific delivery of these tools (including microbial opsins for optogenetics and genetically encoded Ca2+ indicators) has thus far fallen short of versatile targeting to cells jointly defined by many individually selected features. Here, we develop a comprehensive intersectional targeting toolbox including 39 novel vectors for joint-feature-targeted delivery of 13 molecular payloads (including opsins, indicators, and fluorophores), systematic approaches for development and optimization of new intersectional tools, hardware for in vivo monitoring of expression dynamics, and the first versatile single-virus tools (Triplesect) that enable targeting of triply defined cell types.


Subject(s)
Genetic Techniques , Neurons , Optogenetics , Animals , Dependovirus , Genetic Vectors , HEK293 Cells , Humans
2.
Science ; 364(6437): 253, 2019 04 19.
Article in English | MEDLINE | ID: mdl-30948440

ABSTRACT

Physiological needs produce motivational drives, such as thirst and hunger, that regulate behaviors essential to survival. Hypothalamic neurons sense these needs and must coordinate relevant brainwide neuronal activity to produce the appropriate behavior. We studied dynamics from ~24,000 neurons in 34 brain regions during thirst-motivated choice behavior in 21 mice as they consumed water and became sated. Water-predicting sensory cues elicited activity that rapidly spread throughout the brain of thirsty animals. These dynamics were gated by a brainwide mode of population activity that encoded motivational state. After satiation, focal optogenetic activation of hypothalamic thirst-sensing neurons returned global activity to the pre-satiation state. Thus, motivational states specify initial conditions that determine how a brainwide dynamical system transforms sensory input into behavioral output.


Subject(s)
Choice Behavior/physiology , Hypothalamus/cytology , Hypothalamus/physiology , Neural Pathways/physiology , Thirst/physiology , Animals , Female , Mice , Mice, Inbred C57BL , Neurons/physiology , Optogenetics , Sensory Receptor Cells/physiology , Single-Cell Analysis
3.
J Neurosci ; 39(10): 1892-1909, 2019 03 06.
Article in English | MEDLINE | ID: mdl-30626701

ABSTRACT

Emerging studies are providing compelling evidence that the pathogenesis of Huntington's disease (HD), a neurodegenerative disorder with frequent midlife onset, encompasses developmental components. Moreover, our previous studies using a hypomorphic model targeting huntingtin during the neurodevelopmental period indicated that loss-of-function mechanisms account for this pathogenic developmental component (Arteaga-Bracho et al., 2016). In the present study, we specifically ascertained the roles of subpallial lineage species in eliciting the previously observed HD-like phenotypes. Accordingly, we used the Cre-loxP system to conditionally ablate the murine huntingtin gene (Httflx) in cells expressing the subpallial patterning markers Gsx2 (Gsx2-Cre) or Nkx2.1 (Nkx2.1-Cre) in Httflx mice of both sexes. These genetic manipulations elicited anxiety-like behaviors, hyperkinetic locomotion, age-dependent motor deficits, and weight loss in both Httflx;Gsx2-Cre and Httflx;Nkx2.1-Cre mice. In addition, these strains displayed unique but complementary spatial patterns of basal ganglia degeneration that are strikingly reminiscent of those seen in human cases of HD. Furthermore, we observed early deficits of somatostatin-positive and Reelin-positive interneurons in both Htt subpallial null strains, as well as early increases of cholinergic interneurons, Foxp2+ arkypallidal neurons, and incipient deficits with age-dependent loss of parvalbumin-positive neurons in Httflx;Nkx2.1-Cre mice. Overall, our findings indicate that selective loss-of-huntingtin function in subpallial lineages differentially disrupts the number, complement, and survival of forebrain interneurons and globus pallidus GABAergic neurons, thereby leading to the development of key neurological hallmarks of HD during adult life. Our findings have important implications for the establishment and deployment of neural circuitries and the integrity of network reserve in health and disease.SIGNIFICANCE STATEMENT Huntington's disease (HD) is a progressive degenerative disorder caused by aberrant trinucleotide expansion in the huntingtin gene. Mechanistically, this mutation involves both loss- and gain-of-function mechanisms affecting a broad array of cellular and molecular processes. Although huntingtin is widely expressed during adult life, the mutant protein only causes the demise of selective neuronal subtypes. The mechanisms accounting for this differential vulnerability remain elusive. In this study, we have demonstrated that loss-of-huntingtin function in subpallial lineages not only differentially disrupts distinct interneuron species early in life, but also leads to a pattern of neurological deficits that are reminiscent of HD. This work suggests that early disruption of selective neuronal subtypes may account for the profiles of enhanced regional cellular vulnerability to death in HD.


Subject(s)
Brain/growth & development , Huntingtin Protein/physiology , Huntington Disease/physiopathology , Interneurons/physiology , Neurons/physiology , Animals , Anxiety/physiopathology , Behavior, Animal , Brain/pathology , Corpus Striatum/growth & development , Corpus Striatum/pathology , Female , Globus Pallidus/growth & development , Globus Pallidus/pathology , Huntingtin Protein/genetics , Huntington Disease/pathology , Huntington Disease/psychology , Interneurons/ultrastructure , Male , Mice, Inbred C57BL , Mice, Knockout , Motor Cortex/growth & development , Motor Cortex/pathology , Neurons/ultrastructure , Prosencephalon/growth & development , Prosencephalon/pathology , Reelin Protein
4.
Cell ; 170(5): 1013-1027.e14, 2017 Aug 24.
Article in English | MEDLINE | ID: mdl-28823561

ABSTRACT

Reward-seeking behavior is fundamental to survival, but suppression of this behavior can be essential as well, even for rewards of high value. In humans and rodents, the medial prefrontal cortex (mPFC) has been implicated in suppressing reward seeking; however, despite vital significance in health and disease, the neural circuitry through which mPFC regulates reward seeking remains incompletely understood. Here, we show that a specific subset of superficial mPFC projections to a subfield of nucleus accumbens (NAc) neurons naturally encodes the decision to initiate or suppress reward seeking when faced with risk of punishment. A highly resolved subpopulation of these top-down projecting neurons, identified by 2-photon Ca2+ imaging and activity-dependent labeling to recruit the relevant neurons, was found capable of suppressing reward seeking. This natural activity-resolved mPFC-to-NAc projection displayed unique molecular-genetic and microcircuit-level features concordant with a conserved role in the regulation of reward-seeking behavior, providing cellular and anatomical identifiers of behavioral and possible therapeutic significance.


Subject(s)
Reward , Animals , Behavior, Animal , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neural Pathways , Neuroimaging , Prefrontal Cortex/cytology , Prefrontal Cortex/metabolism , Punishment
5.
Neurobiol Dis ; 96: 144-155, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27623015

ABSTRACT

The mutation in huntingtin (mHtt) leads to a spectrum of impairments in the developing forebrain of Huntington's disease (HD) mouse models. Whether these developmental alterations are due to loss- or gain-of-function mechanisms and contribute to HD pathogenesis is unknown. We examined the role of selective loss of huntingtin (Htt) function during development on postnatal vulnerability to cell death. We employed mice expressing very low levels of Htt throughout embryonic life to postnatal day 21 (Hdhd•hyp). We demonstrated that Hdhd•hyp mice exhibit: (1) late-life striatal and cortical neuronal degeneration; (2) neurological and skeletal muscle alterations; and (3) white matter tract impairments and axonal degeneration. Hdhd•hyp embryos also exhibited subpallial heterotopias, aberrant striatal maturation and deregulation of gliogenesis. These results indicate that developmental deficits associated with Htt functions render cells present at discrete neural foci increasingly susceptible to cell death, thus implying the potential existence of a loss-of-function developmental component to HD pathogenesis.


Subject(s)
Developmental Disabilities/genetics , Huntingtin Protein/deficiency , Huntington Disease/complications , Huntington Disease/genetics , Mutation/genetics , Neurodegenerative Diseases/etiology , Age Factors , Animals , Animals, Newborn , Cell Differentiation/genetics , Developmental Disabilities/complications , Disease Models, Animal , Embryo, Mammalian , Gene Expression Regulation, Developmental/genetics , Huntingtin Protein/genetics , Mice , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Neurodegenerative Diseases/complications , Psychomotor Disorders/etiology , Psychomotor Disorders/genetics , RNA, Messenger/metabolism , White Matter/pathology
6.
Proc Natl Acad Sci U S A ; 113(20): 5736-41, 2016 May 17.
Article in English | MEDLINE | ID: mdl-27140644

ABSTRACT

Recent studies have identified impairments in neural induction and in striatal and cortical neurogenesis in Huntington's disease (HD) knock-in mouse models and associated embryonic stem cell lines. However, the potential role of these developmental alterations for HD pathogenesis and progression is currently unknown. To address this issue, we used BACHD:CAG-Cre(ERT2) mice, which carry mutant huntingtin (mHtt) modified to harbor a floxed exon 1 containing the pathogenic polyglutamine expansion (Q97). Upon tamoxifen administration at postnatal day 21, the floxed mHtt-exon1 was removed and mHtt expression was terminated (Q97(CRE)). These conditional mice displayed similar profiles of impairments to those mice expressing mHtt throughout life: (i) striatal neurodegeneration, (ii) early vulnerability to NMDA-mediated excitotoxicity, (iii) impairments in motor coordination, (iv) temporally distinct abnormalities in striatal electrophysiological activity, and (v) altered corticostriatal functional connectivity and plasticity. These findings strongly suggest that developmental aberrations may play important roles in HD pathogenesis and progression.


Subject(s)
Huntingtin Protein/genetics , Huntington Disease/genetics , Action Potentials , Animals , Apoptosis , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Female , GABAergic Neurons/physiology , Gene Expression , Gene Expression Regulation, Developmental , Humans , Huntingtin Protein/metabolism , Huntington Disease/metabolism , Huntington Disease/physiopathology , Male , Mice, Inbred C57BL , Mice, Transgenic , Muscle Strength , Mutant Proteins/genetics , Mutant Proteins/metabolism , Mutation, Missense , Organ Specificity , Rotarod Performance Test
7.
Nat Methods ; 13(4): 325-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26878381

ABSTRACT

Real-time activity measurements from multiple specific cell populations and projections are likely to be important for understanding the brain as a dynamical system. Here we developed frame-projected independent-fiber photometry (FIP), which we used to record fluorescence activity signals from many brain regions simultaneously in freely behaving mice. We explored the versatility of the FIP microscope by quantifying real-time activity relationships among many brain regions during social behavior, simultaneously recording activity along multiple axonal pathways during sensory experience, performing simultaneous two-color activity recording, and applying optical perturbation tuned to elicit dynamics that match naturally occurring patterns observed during behavior.


Subject(s)
Brain Mapping/methods , Brain/physiology , Calcium Signaling , Neural Pathways , Photometry/methods , Social Behavior , Animals , Brain/cytology , Mice
8.
Neoplasia ; 14(1): 34-43, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22355272

ABSTRACT

Inhibitors of PI3K/Akt signaling are being actively developed for tumor therapy owing to the frequent mutational activation of the PI3K-Akt-mTORC1 pathway in many cancers, including glioblastomas (GBMs). NVP-BEZ235 is a novel and potent dual PI3K/mTOR inhibitor that is currently in phase 1/2 clinical trials for advanced solid tumors. Here, we show that NVP-BEZ235 also potently inhibits ATM and DNA-PKcs, the two major kinases responding to ionizing radiation (IR)-induced DNA double-strand breaks (DSBs). Consequently, NVP-BEZ235 blocks both nonhomologous end joining and homologous recombination DNA repair pathways resulting in significant attenuation of DSB repair. In addition, phosphorylation of ATMtargets and implementation of the G(2)/M cell cycle checkpoint are also attenuated by this drug. As a result, NVP-BEZ235 confers an extreme degree of radiosensitization and impairs DSB repair in a panel of GBM cell lines irrespective of their Akt activation status. NVP-BEZ235 also significantly impairs DSB repair in a mouse tumor model thereby validating the efficacy of this drug as a DNA repair inhibitor in vivo. Our results, showing that NVP-BEZ235 is a potent and novel inhibitor of ATM and DNA-PKcs, have important implications for the informed and rational design of clinical trials involving this drug and also reveal the potential utility of NVP-BEZ235 as an effective radiosensitizer for GBMs in the clinic.


Subject(s)
Cell Cycle Proteins/antagonists & inhibitors , DNA Repair/drug effects , DNA-Binding Proteins/antagonists & inhibitors , Imidazoles/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein Serine-Threonine Kinases/antagonists & inhibitors , Quinolines/pharmacology , Radiation-Sensitizing Agents/pharmacology , Tumor Suppressor Proteins/antagonists & inhibitors , Animals , Antineoplastic Agents/pharmacology , Ataxia Telangiectasia Mutated Proteins , Blotting, Western , Cell Separation , DNA Damage/drug effects , Flow Cytometry , Fluorescent Antibody Technique , Humans , Mice , Neoplasms, Experimental/drug therapy , Phosphoinositide-3 Kinase Inhibitors , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/antagonists & inhibitors , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...